LEADER 01126nam2-2200361li-450 001 990000103810203316 005 20180312154649.0 010 $a0-412-39240-2 035 $a0010381 035 $aUSA010010381 035 $a(ALEPH)000010381USA01 035 $a0010381 100 $a20001109d1991----km-y0itay0103----ba 101 0 $aeng 102 $aGB 200 1 $aApplicative high order programming$ethe standard ML perspective$fS. Sokolowski 210 $aLondon$cChapman and Hall$d1991 215 $aXI, 243 p.$cill.$d24 cm 225 2 $aChapman and Hall computing series$v0 410 0$10010010380$12001$aChapman and Hall computing series 610 1 $alinguaggio ml 700 1$aSokolowski,$bStefan$0721414 801 $aSistema bibliotecario di Ateneo dell' Universitą di Salerno$gRICA 912 $a990000103810203316 951 $a005.133 SOK$b0002377 959 $aBK 969 $aTEC 979 $c19940119 979 $c20001110$lUSA01$h1710 979 $c20020403$lUSA01$h1618 979 $aPATRY$b90$c20040406$lUSA01$h1608 996 $aApplicative high order programming$91488498 997 $aUNISA LEADER 01797nam 2200505I 450 001 9910703892403321 005 20150624160431.0 035 $a(CKB)5470000002434803 035 $a(OCoLC)911531329 035 $a(EXLCZ)995470000002434803 100 $a20150624d1987 ua 0 101 0 $aeng 135 $aurbn||||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aEvaluation of the endogenous glucocorticoid hypothesis of denervation atrophy /$fMasaaki Konagaya, Yoko Konagaya and Stephen R. Max 205 $aRevised. 210 1$aBaltimore, MD :$cDepartment of Neurology, University of Maryland School of Medicine,$d[1987]. 215 $a1 online resource (10 pages, 2 unnumbered pages) 225 1 $aNASA CR ;$v182848 300 $aTitle from title screen (viewed on June 24, 2015). 320 $aIncludes bibliographical references (pages 7-10). 606 $aAtrophy$2nasat 606 $aCorticosteroids$2nasat 606 $aNeuromuscular transmission$2nasat 606 $aGlutamine$2nasat 606 $aMuscular tonus$2nasat 615 7$aAtrophy. 615 7$aCorticosteroids. 615 7$aNeuromuscular transmission. 615 7$aGlutamine. 615 7$aMuscular tonus. 700 $aKonagaya$b Masaaki$01396339 702 $aKonagaya$b Yoko 702 $aMax$b Stephen R. 712 02$aUniversity of Maryland at Baltimore.$bDepartment of Neurology, 712 02$aUnited States.$bNational Aeronautics and Space Administration, 712 02$aNational Institutes of Health (U.S.), 801 0$bGPO 801 1$bGPO 906 $aBOOK 912 $a9910703892403321 996 $aEvaluation of the endogenous glucocorticoid hypothesis of denervation atrophy$93456315 997 $aUNINA LEADER 02165nam 2200553 450 001 9910821852903321 005 20230803201616.0 010 $a0-7618-5634-X 035 $a(CKB)3710000000077035 035 $a(EBL)1579859 035 $a(SSID)ssj0001161373 035 $a(PQKBManifestationID)11652200 035 $a(PQKBTitleCode)TC0001161373 035 $a(PQKBWorkID)11128235 035 $a(PQKB)11622538 035 $a(MiAaPQ)EBC1579859 035 $a(Au-PeEL)EBL1579859 035 $a(CaPaEBR)ebr10818896 035 $a(CaONFJC)MIL551552 035 $a(OCoLC)865656747 035 $a(EXLCZ)993710000000077035 100 $a20131227h20142014 uy| 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 10$aJesus consumer $ereframing the debate between faith and consumption /$fMichael L. Klassen 210 1$aLanham :$cUniversity Press of America, Inc.,$d[2014] 210 4$d©2014 215 $a1 online resource (123 p.) 300 $aDescription based upon print version of record. 311 $a0-7618-5633-1 320 $aIncludes bibliographical references. 327 $aContents; Prologue; Introduction; 1 Jesus Landlord; 2 Jesus Amish; 3 Jesus Contractor; 4 Jesus Espresso; 5 Jesus Corporate; Conclusion; Notes; References; About the Author 330 $aJesus Consumer combines modern consumer research with the latest writings on historical Jesus to propose a model for contemporary consumer behavior that pays serious regard to Jesus' "consumption teachings." Klassen argues that Jesus' consumer teachings possess the greatest potential to help us effect positive change in our communities. 606 $aConsumption (Economics)$xReligious aspects$xChristianity 606 $aChristianity and culture 615 0$aConsumption (Economics)$xReligious aspects$xChristianity. 615 0$aChristianity and culture. 676 $a123 700 $aKlassen$b Michael L$01682680 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910821852903321 996 $aJesus consumer$94052970 997 $aUNINA